hat
Tranexamic asid egzèse efè antifibrinolytik li nan blokaj lan revèsib nan lysine-obligatwa sit sou molekil plasminogen.Trainxamic inibit activator plasmonogen endometrièr e konsa anpeche fibrinoliz ak dekonpozisyon nan boul nan san.
eng
Tranexamic acid exerts its antifibrinolytic effect through the reversible blockade of lysine-binding sites on plasminogen molecules.Tranexamic acid inhibits endometrial plasminogen activator and thus prevents fibrinolysis and the breakdown of blood clots.